These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 34778768)

  • 1. VISTA inhibitors in cancer immunotherapy: a short perspective on recent progresses.
    Wu C; Cao X; Zhang X
    RSC Med Chem; 2021 Oct; 12(10):1672-1679. PubMed ID: 34778768
    [TBL] [Abstract][Full Text] [Related]  

  • 2. VISTA: A Mediator of Quiescence and a Promising Target in Cancer Immunotherapy.
    Yuan L; Tatineni J; Mahoney KM; Freeman GJ
    Trends Immunol; 2021 Mar; 42(3):209-227. PubMed ID: 33495077
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of Inhibitors Targeting the V-Domain Ig Suppressor of T Cell Activation Signal Pathway.
    Zheng S; Zhang K; Zhang X; Xiao Y; Wang T; Jiang S
    J Med Chem; 2022 Sep; 65(18):11900-11912. PubMed ID: 36083840
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of active small-molecule modulators targeting the novel immune checkpoint VISTA.
    Li TT; Jiang JW; Qie CX; Xuan CX; Hu XL; Liu WM; Chen WT; Liu J
    BMC Immunol; 2021 Aug; 22(1):55. PubMed ID: 34380434
    [TBL] [Abstract][Full Text] [Related]  

  • 5. VISTA is an immune checkpoint molecule for human T cells.
    Lines JL; Pantazi E; Mak J; Sempere LF; Wang L; O'Connell S; Ceeraz S; Suriawinata AA; Yan S; Ernstoff MS; Noelle R
    Cancer Res; 2014 Apr; 74(7):1924-32. PubMed ID: 24691993
    [TBL] [Abstract][Full Text] [Related]  

  • 6. VISTA immune regulatory effects in bypassing cancer immunotherapy: Updated.
    Mortezaee K; Majidpoor J; Najafi S
    Life Sci; 2022 Dec; 310():121083. PubMed ID: 36265568
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structure and Functional Binding Epitope of V-domain Ig Suppressor of T Cell Activation.
    Mehta N; Maddineni S; Mathews II; Andres Parra Sperberg R; Huang PS; Cochran JR
    Cell Rep; 2019 Sep; 28(10):2509-2516.e5. PubMed ID: 31484064
    [TBL] [Abstract][Full Text] [Related]  

  • 8. VISTA: A Promising Target for Cancer Immunotherapy?
    Tagliamento M; Agostinetto E; Borea R; Brandão M; Poggio F; Addeo A; Lambertini M
    Immunotargets Ther; 2021; 10():185-200. PubMed ID: 34189130
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting the V-Type Immunoglobulin Domain-Containing Suppressor to T Cell Activation (VISTA) with Agonist Monoclonal Antibodies in Autoimmunity.
    Jung M; Bonavida B
    Crit Rev Immunol; 2022; 42(4):37-49. PubMed ID: 37022358
    [TBL] [Abstract][Full Text] [Related]  

  • 10. VISTA: a novel immunotherapy target for normalizing innate and adaptive immunity.
    ElTanbouly MA; Croteau W; Noelle RJ; Lines JL
    Semin Immunol; 2019 Apr; 42():101308. PubMed ID: 31604531
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel Benzimidazoles as Potent Small-Molecule Inhibitors and Degraders of V-Domain Ig Suppressor of T-Cell Activation (VISTA).
    Wang T; Wang K; Zhang Y; Zhang K; Cai S; Jiang S; Xiao Y; Zhang X
    J Med Chem; 2023 Sep; 66(17):11881-11892. PubMed ID: 37594853
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discovery and Optimization of Small-Molecule Ligands for V-Domain Ig Suppressor of T-Cell Activation (VISTA).
    Gabr MT; Gambhir SS
    J Am Chem Soc; 2020 Sep; 142(38):16194-16198. PubMed ID: 32894020
    [TBL] [Abstract][Full Text] [Related]  

  • 13. VISTA: A Novel Checkpoint for Cancer Immunotherapy.
    Gao Y; He Y; Tang Y; Chen ZS; Qu M
    Drug Discov Today; 2024 Jul; 29(7):104045. PubMed ID: 38797321
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Blockade of V-domain immunoglobulin suppressor of T-cell activation reprograms tumour-associated macrophages and improves efficacy of PD-1 inhibitor in gastric cancer.
    Cao Y; Yu K; Zhang Z; Gu Y; Gu Y; Li W; Zhang W; Shen Z; Xu J; Qin J
    Clin Transl Med; 2024 Feb; 14(2):e1578. PubMed ID: 38356419
    [TBL] [Abstract][Full Text] [Related]  

  • 15. VISTA, a novel mouse Ig superfamily ligand that negatively regulates T cell responses.
    Wang L; Rubinstein R; Lines JL; Wasiuk A; Ahonen C; Guo Y; Lu LF; Gondek D; Wang Y; Fava RA; Fiser A; Almo S; Noelle RJ
    J Exp Med; 2011 Mar; 208(3):577-92. PubMed ID: 21383057
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rationally targeted anti-VISTA antibody that blockades the C-C' loop region can reverse VISTA immune suppression and remodel the immune microenvironment to potently inhibit tumor growth in an Fc independent manner.
    Thakkar D; Paliwal S; Dharmadhikari B; Guan S; Liu L; Kar S; Tulsian NK; Gruber JJ; DiMascio L; Paszkiewicz KH; Ingram PJ; D Boyd-Kirkup J
    J Immunother Cancer; 2022 Feb; 10(2):. PubMed ID: 35131861
    [TBL] [Abstract][Full Text] [Related]  

  • 17. VSIG-3 as a ligand of VISTA inhibits human T-cell function.
    Wang J; Wu G; Manick B; Hernandez V; Renelt M; Erickson C; Guan J; Singh R; Rollins S; Solorz A; Bi M; Li J; Grabowski D; Dirkx J; Tracy C; Stuart T; Ellinghuysen C; Desmond D; Foster C; Kalabokis V
    Immunology; 2019 Jan; 156(1):74-85. PubMed ID: 30220083
    [TBL] [Abstract][Full Text] [Related]  

  • 18. V-domain Ig-containing suppressor of T-cell activation (VISTA), a potentially targetable immune checkpoint molecule, is highly expressed in epithelioid malignant pleural mesothelioma.
    Muller S; Victoria Lai W; Adusumilli PS; Desmeules P; Frosina D; Jungbluth A; Ni A; Eguchi T; Travis WD; Ladanyi M; Zauderer MG; Sauter JL
    Mod Pathol; 2020 Feb; 33(2):303-311. PubMed ID: 31537897
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immune-checkpoint protein VISTA in allergic, autoimmune disease and transplant rejection.
    Zheng M; Zhang Z; Yu L; Wang Z; Dong Y; Tong A; Yang H
    Front Immunol; 2023; 14():1194421. PubMed ID: 37435070
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immune-checkpoint proteins VISTA and PD-1 nonredundantly regulate murine T-cell responses.
    Liu J; Yuan Y; Chen W; Putra J; Suriawinata AA; Schenk AD; Miller HE; Guleria I; Barth RJ; Huang YH; Wang L
    Proc Natl Acad Sci U S A; 2015 May; 112(21):6682-7. PubMed ID: 25964334
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.